Cardinal Capital Management Inc (Canada)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-400
Closed -$13K – 75
2020
Q2
$13K Sell
400
-500
-56% -$16K ﹤0.01% 66
2020
Q1
$27K Hold
900
– – ﹤0.01% 61
2019
Q4
$26K Hold
900
– – ﹤0.01% 60
2019
Q3
$23K Hold
900
– – ﹤0.01% 53
2019
Q2
$23K Hold
900
– – ﹤0.01% 42
2019
Q1
$24K Hold
900
– – ﹤0.01% 45
2018
Q4
$21K Hold
900
– – ﹤0.01% 45
2018
Q3
$21K Hold
900
– – ﹤0.01% 58
2018
Q2
$21K Hold
900
– – ﹤0.01% 62
2018
Q1
$22K Hold
900
– – ﹤0.01% 61
2017
Q4
$24K Hold
900
– – ﹤0.01% 66
2017
Q3
$22K Hold
900
– – ﹤0.01% 59
2017
Q2
$19K Buy
+900
New +$18.2K ﹤0.01% 60

Other funds holding NVO

Cardinal Capital Management Inc (Canada)'s NVO Position: Q3 2020 in Review

Cardinal Capital Management Inc (Canada) sold out of Novo Nordisk (NVO) in Q3 2020, closing a stake of 400 shares — an estimated $13K sold.

Cardinal Capital Management Inc (Canada) first reported a position in NVO in Q2 2017 and held it in 13 quarters. The position peaked at $27K in Q1 2020. 660 funds tracked by Wall St. Rank hold NVO as of Q3 2020.

  • Cardinal Capital Management Inc (Canada) reported no remaining Novo Nordisk position as of Q3 2020 after selling out during the quarter.
  • Cardinal Capital Management Inc (Canada) sold 400 Novo Nordisk shares in Q3 2020, an estimated $13K.
  • Cardinal Capital Management Inc (Canada) first reported a position in Novo Nordisk in Q2 2017 and held it in 13 quarters.
  • Cardinal Capital Management Inc (Canada)'s Novo Nordisk position peaked at $27K in Q1 2020.
  • 660 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2020.

Based on Cardinal Capital Management Inc (Canada)'s 13F filing for Q3 2020, filed 13 Oct 2020.